NASDAQ:PCVX

Vaxcyte Stock Insider Trading

etoro logo Buy PCVX
*Your capital is at risk
$57.03
-1.18 (-2.03%)
At Close: Jul 13, 2026

Vaxcyte Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -18.08. In total, the insiders bought 892.49K and sold 307.36K PCVX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-18.08
Buy 892.49K shares
Sell 307.36K shares
46% Buy Activity
Strong Negative Correlation
Sell Signal Medium Confidence
Jun 26, 2026

Analysis Breakdown:

  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 06, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guggenhime Andrew
President And CFO
CEO / President 10 000
Value: $53.5K
Jul 06, 2026
Buy
Common Stock
M-Exempt
Guggenhime Andrew
President And CFO
CEO / President 10 000
Value: $53.5K
Jul 06, 2026
Sell
Common Stock
S-Sale
Guggenhime Andrew
President And CFO
CEO / President 7 913
Value: $452.3K
Jul 06, 2026
Sell
Common Stock
S-Sale
Guggenhime Andrew
President And CFO
CEO / President 2 087
Value: $120.6K
Jul 01, 2026
Buy
Common Stock
M-Exempt
Wassil Jim
Chief Operating Officer
C-Suite Officer 516
Value: $3K
Jul 01, 2026
Sell
Common Stock
S-Sale
Wassil Jim
Chief Operating Officer
C-Suite Officer 1 788
Value: $100.2K
Jul 01, 2026
Sell
Common Stock
S-Sale
Wassil Jim
Chief Operating Officer
C-Suite Officer 456
Value: $26.2K
Jul 01, 2026
Sell
Common Stock
S-Sale
Wassil Jim
Chief Operating Officer
C-Suite Officer 6
Value: $347
Jul 01, 2026
Buy
Stock Option (right to buy)
M-Exempt
Wassil Jim
Chief Operating Officer
C-Suite Officer 516
Value: $3K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 602
Value: $33.3K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 356
Value: $19.7K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 312
Value: $17.0K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 207
Value: $11.2K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 6 417
Value: $360.1K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 9 137
Value: $505.0K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 6 683
Value: $362.7K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 191
Value: $10.7K
Jun 26, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 332
Value: $18.6K
Jun 22, 2026
Buy
Stock Option (right to buy)
A-Award
Slaoui Moncef
Director
Director 26 061
Value: $1.36M
Jun 18, 2026
Sell
Common Stock
S-Sale
Guggenhime Andrew
President And CFO
CEO / President 10 000
Value: $530.0K
Jun 18, 2026
Buy
Common Stock
M-Exempt
Guggenhime Andrew
President And CFO
CEO / President 10 000
Value: $53.5K
Jun 18, 2026
Buy
Stock Option (right to buy)
M-Exempt
Guggenhime Andrew
President And CFO
CEO / President 10 000
Value: $53.5K
Jun 18, 2026
Buy
Stock Option (right to buy)
M-Exempt
Pickering Grant
Chief Executive Officer
CEO / President 225
Value: $403
Jun 18, 2026
Sell
Common Stock
S-Sale
Pickering Grant
Chief Executive Officer
CEO / President 1 000
Value: $52.5K
Jun 18, 2026
Buy
Common Stock
M-Exempt
Pickering Grant
Chief Executive Officer
CEO / President 225
Value: $403

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VAXCYTE, INC.
Vaxcyte
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a co...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE